Association Study Confirmed Susceptibility Loci with Keloid in the Chinese Han Population

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Zhu, Fei ^a   Wu, Baoyu ^a   Li, Ping ^a   Wang, Jianbo ^a   Tang, Huayang ^a   Liu, Ye ^a   Zuo, Xianbo ^a   Cheng, Hui ^a   Ding, Yantao ^a   Wang, Wen ^a   Zhai, Yujuan ^a   Qian, Fangfang ^a   Wang, Wenju ^a   Yuan, Xiangfeng ^a   Wang, Jing ^a   Ha, Weiwei ^a   Hou, Junsheng ^a   Zhou, Fusheng ^a   Wang, Yin ^a   Gao, Jinping ^a   Sheng, Yujun ^a   Sun, Liangdan ^a   Liu, Jianjun ^a   Yang, Sen ^a   Zhang, Xuejun ^a   more..

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD3 PROTEIN; SMAD6 PROTEIN; UBIQUITIN PROTEIN LIGASE NEDD4;

ADULT; AGED; ARTICLE; CHILD; CHINESE; CHROMOSOME 15Q; CHROMOSOME 15Q21.3; CHROMOSOME 1Q; CHROMOSOME 1Q41; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOXL2 GENE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; KELOID; MAJOR CLINICAL STUDY; MALE; NEDD4 GENE; PRESCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SMAD3 GENE; SMAD6 GENE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; ETHNIC GROUPS; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; KELOID; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84877136129     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062377     Document Type: Article

References (26)

1. Brown JJ, Bayat A, (2009) Genetic susceptibility to raised dermal scarring. Br J Dermatol 161: 8-18.
2. Phan TT, Lim IJ, Bay BH, Qi R, Longaker MT, et al. (2003) Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro. Am J Physiol Cell Physiol 284: C860-869.
3. Kelly AP, (2004) Medical and surgical therapies for keloids. Dermatol Ther 17: 212-218.
4. Bayat A, McGrouther DA, Ferguson MW, (2003) Skin scarring. Bmj 326: 88-92.
5. Brown BC, McKenna SP, Siddhi K, McGrouther DA, Bayat A, (2008) The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg 61: 1049-1058.
6. Marneros AG, Norris JE, Watanabe S, Reichenberger E, Olsen BR, (2004) Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol 122: 1126-1132.
7. Bayat A, Arscott G, Ollier WE, McGrouther DA, Ferguson MW, (2005) Keloid disease: clinica relevance of single versus multiple site scars. Br J Plast Surg 58: 28-37.
8. Marneros AG, Krieg T, (2004) Keloids-clinical diagnosis, pathogenesis, and treatment options. J Dtsch Dermatol Ges 2: 905-913.
9. Shih B, Bayat A, (2010) Genetics of keloid scarring. Arch Dermatol Res 302: 319-339.
10. Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW (2003) Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg 111: 535-543; discussion 544-536.
11. Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW, (2004) Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease. Exp Dermatol 13: 120-124.
12. Lu WS, Zuo XB, Wang ZX, Cai LQ, Zhu F, et al. (2011) Association of HLA haplotype with keloids in Chinese Hans. Burns 37: 794-799.
13. Kruglyak L, (1999) Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 22: 139-144.
14. Nakashima M, Chung S, Takahashi A, Kamatani N, Kawaguchi T, et al. (2010) A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. Nat Genet 42: 768-771.
15. Cordell HJ, Clayton DG, (2005) Genetic association studies. Lancet 366: 1121-1131.
16. Brown JJ, Ollier W, Arscott G, Ke X, Lamb J, Day P, Bayat A, (2008) Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro-Caribbeans. Exp Dermatol 17: 610-613.
17. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
18. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
19. Kumar S, Harvey KF, Kinoshita M, Copeland NG, Noda M, et al. (1997) cDNA cloning, expression analysis, and mapping of the mouse Nedd4 gene. Genomics 40: 435-443.
20. Anan T, Nagata Y, Koga H, Honda Y, Yabuki N, et al. (1998) Human ubiquitin-protein ligase Nedd4: expression, subcellular localization and selective interaction with ubiquitin-conjugating enzymes. Genes Cells 3: 751-763.
21. Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, et al. (2007) NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128: 129-139.
22. Vecchione A, Marchese A, Henry P, Rotin D, Morrione A, (2003) The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor. Mol Cell Biol 23: 3363-3372.
23. Moren A, Imamura T, Miyazono K, Heldin CH, Moustakas A, (2005) Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J Biol Chem 280: 22115-22123.
24. Izzi L, Attisano L, (2006) Ubiquitin-dependent regulation of TGFbeta signaling in cancer. Neoplasia 8: 677-688.
25. Izzi L, Attisano L, (2004) Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation. Oncogene 23: 2071-2078.
26. Bettinger DA, Yager DR, Diegelmann RF, Cohen IK, (1996) The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 98: 827-833.